Viewing Study NCT00421434


Ignite Creation Date: 2025-12-25 @ 2:32 AM
Ignite Modification Date: 2025-12-28 @ 12:09 AM
Study NCT ID: NCT00421434
Status: COMPLETED
Last Update Posted: 2008-09-25
First Post: 2007-01-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Nitazoxanide, Peginterferon, and Ribavirin Combination Therapies in the Treatment of Chronic Hepatitis C
Sponsor: Romark Laboratories L.C.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: RM01-3036
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Romark Laboratories, L.C.
Old Organization: Romark Laboratories, L.C.

Collaborators